0001493152-23-041691.txt : 20231116
0001493152-23-041691.hdr.sgml : 20231116
20231116164511
ACCESSION NUMBER: 0001493152-23-041691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAUM MARK L
CENTRAL INDEX KEY: 0001274282
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 231415226
MAIL ADDRESS:
STREET 1: C/O IMPRIMIS PHARMACEUTICALS, INC
STREET 2: 12264 EL CAMINO REAL, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: HARROW HEALTH, INC.
DATE OF NAME CHANGE: 20181228
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
4
1
ownership.xml
X0508
4
2023-11-16
0
0001360214
HARROW, INC.
HROW
0001274282
BAUM MARK L
C/O HARROW HEALTH, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-11-16
4
P
0
7500
8.11
A
2022961
D
These shares were purchased in a single transaction at a price of $8.1097.
/s/ Mark L Baum
2023-11-16